Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
Reported purchases exceed sales by $308.5KOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
| Insider trading | Relationship |
|---|
Company profile
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Date |
|---|
| Transaction |
|---|
| Cost |
|---|
| Shares |
|---|
| Value |
|---|
| Shares total |
|---|
| SEC Form 4 |
|---|
| Chaudhary Zuraiz | See Remarks | Dec 12 '25 | Buy | $3.50 | 2,500 | $8,750 | 12,500 | Dec 12 06:00 PM |
| Golden Arthur F | Director | Nov 24 '25 | Buy | $3.44 | 9,868 | $33,946 | 60,602 | Nov 25 09:00 PM |
| Golden Arthur F | Director | Nov 21 '25 | Buy | $2.87 | 20,532 | $58,927 | 50,734 | Nov 24 07:13 AM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.